COVID and Diabetes Assessment Study - Clinical Trial

¿Cuál es el Propósito de este estudio?

People who join this study will answer surveys by phone, online, or in person. They will also give regular blood samples. Some people will be asked to do extra tests that check how their body handles sugar, measure special biomarkers, and look at how well their blood vessels work. Participants will be followed for two years. The study will also use information from their electronic health records over time.

¿Cuál es la Condición que se está estudiando?

Diabetes.

A diagnosis of Type 1 or Type 2 Diabetes in the last 6 months.

¿Quién puede participar en el Estudio?

Adults 18 years and older and who have been diagnosed with type 1 or type 2 diabetes in the last 6 months.

Grupo etario
Adultos

¿Qué Implica?

The goal of this study is to learn more about what happens during the first one to two years after someone is diagnosed with diabetes. The study will look at how COVID 19 and other factors might affect people who are newly diagnosed with diabetes.

Detalles del Estudio

Título Completo
Estudio de evaluación de COVID y Diabetes
Investigador Principal
Ranee Chatterjee Montgomery, MD, MPH
Especialista en medicina interna
Número de Protocolo
IRB: PRO00115442
Fase
Fase N/A
Estado de inscripción
Abierto para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health